KM Financial Solutions | More drugmakers hike U.S. prices as new year begins
60046
post-template-default,single,single-post,postid-60046,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

More drugmakers hike U.S. prices as new year begins

More drugmakers hike U.S. prices as new year begins

Drugmakers including
Bristol-Myers Squibb Co, Gilead Sciences Inc,
and Biogen Inc hiked U.S. list prices on more than 50
drugs on Wednesday, bringing total New Year’s Day drug price
increases to more than 250, according to data analyzed by
healthcare research firm 3 Axis Advisors.

No Comments

Sorry, the comment form is closed at this time.